| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Case of Alopecia Areata Following Alemtuzumab in a Patient with Multiple Sclerosis
|
Aljaberi, Kholoud Mohamed
|
|
|
80 |
C |
p.
|
artikel
|
| 2 |
A Case of Myasthenia Gravis Treated with Ocrelizumab
|
Aljaberi, Kholoud Mohamed
|
|
|
80 |
C |
p.
|
artikel
|
| 3 |
Acute Relapses of Neuromyelitis Optica Spectrum Disorder After COVID-19 Vaccination Shot, a Case Series from Iran
|
Mehdipour, Roshanak
|
|
|
80 |
C |
p.
|
artikel
|
| 4 |
Adverse Event and Blood Pressure Profile of Disease-Modifying Therapy in Multiple Sclerosis
|
Aljarallah, Salman Ahmad
|
|
|
80 |
C |
p.
|
artikel
|
| 5 |
Aerobic cycling reduces fatigue and improves pain in persons with multiple sclerosis: A preliminary study
|
Simmons, Sarah B
|
|
|
80 |
C |
p.
|
artikel
|
| 6 |
Albumin Quotient in Patients with Neuromyelitis Optica Spectrum Disorders (NMOSD)
|
Jerbi, Khouloud
|
|
|
80 |
C |
p.
|
artikel
|
| 7 |
Alexithymia in Multiple Sclerosis: Clinical and Radiological Correlations
|
Ali, Amal Hadj
|
|
|
80 |
C |
p.
|
artikel
|
| 8 |
A Longitudinal Study of Cognitive Function in a Tunisian Cohort of Multiple Sclerosis
|
Sellami, Sirine
|
|
|
80 |
C |
p.
|
artikel
|
| 9 |
Alopecia Universalis in a MS Patient After First Dose of Ocrelizumab Switched from Rituximab
|
Nahayati, Mohammadali
|
|
|
80 |
C |
p.
|
artikel
|
| 10 |
Anaesthetic management of people with multiple sclerosis
|
Dubuisson, N.
|
|
|
80 |
C |
p.
|
artikel
|
| 11 |
A Novel Rabbit Model of EBV Infection to Understand the Role of the Virus in the Pathogenesis Multiple Sclerosis
|
Khan, Gulfaraz
|
|
|
80 |
C |
p.
|
artikel
|
| 12 |
Anti-Mullerian Hormone Level and Fecundity in Female Egyptian Multiple Sclerosis Patients
|
Ismail, Samah Ali Ahmed
|
|
|
80 |
C |
p.
|
artikel
|
| 13 |
An Unusual Presentation of Multiple Sclerosis as Acute Vestibular Syndrome: A Case Report
|
Muddassir, Rabia
|
|
|
80 |
C |
p.
|
artikel
|
| 14 |
Anxiety and Depression in Patients with Neuromyelitis Optica Spectrum Disorders (NMOSD)
|
Jerbi, Khouloud
|
|
|
80 |
C |
p.
|
artikel
|
| 15 |
Anxiety and Fatigue as Predictors of Pain Severity and Interference Among Patients Living with Multiple Sclerosis
|
Morris, Linzette Deidre
|
|
|
80 |
C |
p.
|
artikel
|
| 16 |
Anxiety, Depression, and Quality of Life in Multiple Sclerosis: A Retrospective Study
|
Dhia, Rihab Ben
|
|
|
80 |
C |
p.
|
artikel
|
| 17 |
Assessing the Clinical Value of the Central Vein Sign in Patients with T2 Hyperintense Lesions on MRI
|
Oreja-Guevara, Celia
|
|
|
80 |
C |
p.
|
artikel
|
| 18 |
Astrocyte Activation Precedes Disease Onset in Experimental Autoimmune Encephalomyelitis
|
Bakirtzis, Christos
|
|
|
80 |
C |
p.
|
artikel
|
| 19 |
A Study of Demyelinating Optic Neuritis: A Neuro-Ophthalmological Perspective
|
Chakraborty, Rajarshi
|
|
|
80 |
C |
p.
|
artikel
|
| 20 |
Atypical Presentations in MOG Antibody Associated Disorders
|
Sellami, Sirine
|
|
|
80 |
C |
p.
|
artikel
|
| 21 |
Autoimmune Diseases Among Patients with Multiple Sclerosis
|
Aldalaan, Abdulaziz
|
|
|
80 |
C |
p.
|
artikel
|
| 22 |
Autologous Haematopoietic Stem Cell Transplantation for Multiple Sclerosis: First Experience in UAE
|
Mir, Ruqqia
|
|
|
80 |
C |
p.
|
artikel
|
| 23 |
Autologous hematopoietic stem cell transplantation is superior to alemtuzumab in patients with highly active relapsing multiple sclerosis and severe disability
|
Vaisvilas, Mantas
|
|
|
80 |
C |
p.
|
artikel
|
| 24 |
Benefits of sphingosine-1-phosphate receptor modulators in relapsing MS estimated with a treatment sequence model
|
Corsten, Cato E.A.
|
|
|
80 |
C |
p.
|
artikel
|
| 25 |
Cancer risk, disease-modifying therapy, and age in multiple sclerosis: A retrospective population-based cohort study
|
Greenfield, Jamie
|
|
|
80 |
C |
p.
|
artikel
|
| 26 |
Can neurofilament lightchain as endpoint in Phase 2 derisk clinical disability worsening in Phase 3 in multiple sclerosis?
|
Collignon, Olivier
|
|
|
80 |
C |
p.
|
artikel
|
| 27 |
Cardiovascular Risk Profile After Fingolimod Treatment in Iranian Patients with Multiple Sclerosis
|
Kasbi, Naghmeh Abbasi
|
|
|
80 |
C |
p.
|
artikel
|
| 28 |
Cerebral Hemodynamics Changes in Patients with Relapsing Remittent Multiple Sclerosis: An Egyptian Study
|
Elnabil, Lobna
|
|
|
80 |
C |
p.
|
artikel
|
| 29 |
Cerebrospinal fluid cell counts in autoimmune encephalitis: Technological limitations and transparent reporting of laboratory data
|
Frater, John L
|
|
|
80 |
C |
p.
|
artikel
|
| 30 |
Cerebrospinal Fluid Neurofilament Light Chain as a Biomarkers of Disease Activity and Disability in NMOSD
|
Bouattour, Nadia
|
|
|
80 |
C |
p.
|
artikel
|
| 31 |
Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis
|
Toscano, Simona
|
|
|
80 |
C |
p.
|
artikel
|
| 32 |
Cerebrovascular Changes and Multiple Sclerosis
|
Shehata, Ghaydaa A.
|
|
|
80 |
C |
p.
|
artikel
|
| 33 |
Characteristics and predictors of disease course in children initially presenting with ADEM
|
Rutatangwa, Alice
|
|
|
80 |
C |
p.
|
artikel
|
| 34 |
Characteristics of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Patients at Cleveland Clinic Abu Dhabi: A Case Series
|
Altelly, Ahmad
|
|
|
80 |
C |
p.
|
artikel
|
| 35 |
Characteristics of Patients with Newly Diagnosed Multiple Sclerosis: A Five-Year Study at Benghazi Medical Center, Benghazi, Libya
|
Elshukri, Majda
|
|
|
80 |
C |
p.
|
artikel
|
| 36 |
Characteristics of Pediatric Onset Multiple Sclerosis in the Emirati Population from Cleveland Clinic Abu Dhabi
|
Altelly, Ahmad
|
|
|
80 |
C |
p.
|
artikel
|
| 37 |
Characteristics of Seropositive Neuromyelitis Optica Spectrum Disorder in Emirati Patients at Cleveland Clinic Abu Dhabi
|
Krishnan, Omeesha Sanjay
|
|
|
80 |
C |
p.
|
artikel
|
| 38 |
Circular RNA Circ_0005402 and ANXA2 Gene Expression as Potential Biomarkers for Multiple Sclerosis in a Cohort of Egyptian Patients
|
Eldine, Nada Mohamed Nasr
|
|
|
80 |
C |
p.
|
artikel
|
| 39 |
Clinical and radiologic differences between early onset, late onset, and very late onset adult multiple sclerosis
|
Palathinkara, Murali
|
|
|
80 |
C |
p.
|
artikel
|
| 40 |
Clinical Characteristics and Demographics of NMOSD/MOGAD from a Single Tertiary Center in Dubai, UAE
|
Inshasi, Jihad
|
|
|
80 |
C |
p.
|
artikel
|
| 41 |
Clinical Spectrum, Serological Pattern and Outcome of Seropositive Autoimmune Encephalitis at King Abdulaziz Medical City, MNGHA, Riyadh, KSA
|
Khatri, Ismail A.
|
|
|
80 |
C |
p.
|
artikel
|
| 42 |
Cognitive Impairment in Multiple Sclerosis: the Role of Sleep Disorders
|
Sarhan, Noha Taha
|
|
|
80 |
C |
p.
|
artikel
|
| 43 |
Colitis Due to Anti-B Cell Therapy: A Clinical Reality
|
Aljaberi, Kholoud Mohamed
|
|
|
80 |
C |
p.
|
artikel
|
| 44 |
Coping Strategies and their Impact on Tunisian Patients with Multiple Sclerosis
|
Ali, Amal Hadj
|
|
|
80 |
C |
p.
|
artikel
|
| 45 |
Corrigendum to “The 2015 IPND Criteria Increases the Yield in Diagnosis of Neuromyelitis Optica Spectrum Disorder in Thai Patients Compared to the 2006 Diagnostic Criteria” [Multiple Sclerosis and Related Disorders Volume 43 year 2020, article number 102218]
|
Rattanathamsakul, Natthapon
|
|
|
80 |
C |
p.
|
artikel
|
| 46 |
Cortical Lesions in a Sample of Egyptian MS Patients
|
Mashaal, Alaa Gamal
|
|
|
80 |
C |
p.
|
artikel
|
| 47 |
Could Procalcitonin Play a Role as a Novel Potential Disease Inflammatory Biomarker in Multiple Sclerosis?
|
Moghadam, Nahid Beladi
|
|
|
80 |
C |
p.
|
artikel
|
| 48 |
COVID-19 Infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination in Patients with Multiple Sclerosis and Other Neurological Disorders
|
Panah, Mohammad Yazdan
|
|
|
80 |
C |
p.
|
artikel
|
| 49 |
Cross-Cultural Adaptation and Psychometric Evaluation of the Multiple Sclerosis Walking Scale-12 Arabic Version
|
Aldughmi, Mayis
|
|
|
80 |
C |
p.
|
artikel
|
| 50 |
De-Escalation of Anti-CD20 Monoclonal Antibodies to Low-Moderate Efficacy Disease-Modifying Treatments in Patients with Relapse-Remitting Multiple Sclerosis: The Initial Iranian Experience
|
Paybast, Sepideh
|
|
|
80 |
C |
p.
|
artikel
|
| 51 |
Design and Baseline Characteristics of Phase 3, Double-Blind, Randomised Trials Evaluating the Efficacy and Safety of Evobrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis (evolutionRMS 1 and 2)
|
Montalban, Xavier
|
|
|
80 |
C |
p.
|
artikel
|
| 52 |
Detection of Pattern of Some Unusual Signs and Symptoms of Multiple Sclerosis
|
Shehata, Ghaydaa
|
|
|
80 |
C |
p.
|
artikel
|
| 53 |
Differences in Retinal Nerve Fiber Layer Atrophy Between Multiple Sclerosis Subtypes: A Tunisian Cohort
|
Rim, Smaoui
|
|
|
80 |
C |
p.
|
artikel
|
| 54 |
Dimethyl Fumarate (Sclera) for Treatment of Relapsing Multiple Sclerosis: First Experience in the Department of Neurology in Oran
|
Oudrer,
|
|
|
80 |
C |
p.
|
artikel
|
| 55 |
Dimethyl fumarate treatment in relapsing remitting MS changes the inflammatory CSF protein profile by a prominent decrease in T-helper 1 immunity
|
Hojjati, Sara
|
|
|
80 |
C |
p.
|
artikel
|
| 56 |
Discontinuation of dimethyl fumarate in multiple sclerosis - a nationwide study
|
Roar, Malte
|
|
|
80 |
C |
p.
|
artikel
|
| 57 |
Disease Progression in Tunisian Pediatric Multiple Sclerosis
|
Gharsallah, Farah
|
|
|
80 |
C |
p.
|
artikel
|
| 58 |
Does Dietary Habits Influence on the Occurrence of Late-Onset Multiple Sclerosis? a Population-Based Case-Control Study
|
Kasbi, Naghmeh Abbasi
|
|
|
80 |
C |
p.
|
artikel
|
| 59 |
Does multilingualism act as a protective factor (cognitive reserve) against cognitive impairment in multiple sclerosis?: A retrospective cohort study
|
Morrow, Sarah A.
|
|
|
80 |
C |
p.
|
artikel
|
| 60 |
Drug-Drug Interaction and Poly Pharmacy Among Second Line Treatment Users of Multiple Sclerosis and Neuromyelitis Optical Spectrum Disorder Patients
|
Shima,
|
|
|
80 |
C |
p.
|
artikel
|
| 61 |
Dysphagia in Relation with Depression, Anxiety, Fatigue, Sleep Quality, and Pain in Multiple Sclerosis
|
Hamidi, Majid
|
|
|
80 |
C |
p.
|
artikel
|
| 62 |
Early Initiation of High Efficacy Disease Modifying Therapies in Naïve Relapsing Remitting Multiple Sclerosis Patients Reduce Disease Activity and Disability
|
Alroughani, Raed
|
|
|
80 |
C |
p.
|
artikel
|
| 63 |
Early Use of Cladribine Tablets Impact on Disease Control in Patients with Relapsing Multiple Sclerosis: Cohort Study from Tawam Hospital, UAE
|
Hassan, Ahmed Mahmoud
|
|
|
80 |
C |
p.
|
artikel
|
| 64 |
EDSS and Infratentorial White Matter Lesion Volume are Considered Predictors of Fatigue Severity in RRMS
|
Hassan, Shady Mohamed Safwat Mohamed Tawfik
|
|
|
80 |
C |
p.
|
artikel
|
| 65 |
Effectiveness and Safety Results from Real World Experience for Cladribine Tablets in Management of Relapsing Multiple Sclerosis in Qatar- 30 Months Follow Up
|
Baniamer, Yahia Zakarya
|
|
|
80 |
C |
p.
|
artikel
|
| 66 |
Effectiveness of Tibial Nerve Stimulation in Neurogenic Lower Urinary Tract Dysfunction Among Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis
|
Mosaddeghi-Heris, Reza
|
|
|
80 |
C |
p.
|
artikel
|
| 67 |
Effect of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, on Patient-Reported Vitality and Mental Health in Patients with Relapsing Multiple Sclerosis in a Phase 2 Trial
|
Vermersch, Patrick
|
|
|
80 |
C |
p.
|
artikel
|
| 68 |
Effect of Fasting on Multiple Sclerosis Symptoms
|
Souissi, Amira
|
|
|
80 |
C |
p.
|
artikel
|
| 69 |
Effects of Acupuncture on Fatigue, Disability, Psychological Problems, and Sleep Quality in People with Relapsing-Remitting Multiple Sclerosis: A Randomized Controlled Trial
|
Khodaie, Faezeh
|
|
|
80 |
C |
p.
|
artikel
|
| 70 |
Effects of 6-Month Treatment with Dimethyl Fumarate (DMF) on Treatment Satisfaction and Work Improvement in Patients with Relapsing Remitting Multiple Sclerosis (RRMS) (Interim Data Analysis)
|
Abolfazli, Roya
|
|
|
80 |
C |
p.
|
artikel
|
| 71 |
Effects of tele-exercise training on physical and mental health and quality of life in multiple sclerosis: Do the effects differ by modality and clinical disease course?
|
Najafi, Parisa
|
|
|
80 |
C |
p.
|
artikel
|
| 72 |
Effects of transcranial alternating current stimulation on cognitive function in people with multiple sclerosis: A randomized controlled trial
|
Hsu, Wan-Yu
|
|
|
80 |
C |
p.
|
artikel
|
| 73 |
Efficacy and Safety in Patients with Multiple Sclerosis Treated with Ocrelizumab
|
Moufakkir, Rim
|
|
|
80 |
C |
p.
|
artikel
|
| 74 |
Efficacy and Safety of Ocrelizumab in Pediatric Multiple Sclerosis
|
Altelly, Ahmad
|
|
|
80 |
C |
p.
|
artikel
|
| 75 |
Efficacy and Safety of Rituximab in Moroccan Multiple Sclerosis Patients
|
Maarad, Najoua
|
|
|
80 |
C |
p.
|
artikel
|
| 76 |
Efficacy & Safety of Natalizumab's Extended Interval Dosing in Relapsing Remitting Multiple Sclerosis
|
Al-Mahdawi, Akram Mohammed
|
|
|
80 |
C |
p.
|
artikel
|
| 77 |
Electrical stimulation therapy for pain and related symptoms in multiple sclerosis: A systematic review and meta-analysis
|
Wu, Fan
|
|
|
80 |
C |
p.
|
artikel
|
| 78 |
Establishment of the Saudi National MS Registry and Its Use in the Execution of Managed Entry Agreements for Pharmaceuticals
|
Bunyan, Reem F.
|
|
|
80 |
C |
p.
|
artikel
|
| 79 |
Evaluating the Validity of Data Sets in National Neuromyelitis Optica Spectrum Disorders Registry System in Iran
|
Eskandarieh, Sharareh
|
|
|
80 |
C |
p.
|
artikel
|
| 80 |
Evolution of Brain MRI Lesions in Paediatric Myelin-Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) and Its Relevance to Disease Course
|
Abdel-Mannan, Omar
|
|
|
80 |
C |
p.
|
artikel
|
| 81 |
Expert Opinion on the Pharmacological Management of Multiple Sclerosis in Women of Childbearing Age in Iraq
|
Hassoun, Hayder K.
|
|
|
80 |
C |
p.
|
artikel
|
| 82 |
Explaining the Individual Challenges of Women Affected by Neuromyelitis Optica
|
Shabany, Maryam
|
|
|
80 |
C |
p.
|
artikel
|
| 83 |
Exploring the Association Between Multiple Sclerosis and Takotsubo Syndrome: A Literature Review
|
Sayeed, Maryam
|
|
|
80 |
C |
p.
|
artikel
|
| 84 |
Factors Affecting Community Mobility Among Patients with Multiple Sclerosis: A Cross-Sectional Study
|
Mukhtar, Shatha Mohammed
|
|
|
80 |
C |
p.
|
artikel
|
| 85 |
Factors Associated with Altered Quality of Life in Neuromyelitis Optica Spectrum Disorder in a Tunisian Cohort
|
Chaibi, Azza
|
|
|
80 |
C |
p.
|
artikel
|
| 86 |
Factors Associated with Fatigue in Neuromyelitis Optica Spectrum Disorder in a Tunisian Cohort
|
Adouania, Mahdi
|
|
|
80 |
C |
p.
|
artikel
|
| 87 |
Factors Associated with Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder in a Tunisian Cohort
|
Majoul, Slim
|
|
|
80 |
C |
p.
|
artikel
|
| 88 |
Factors Contributing to Fatigability in Individuals with Multiple Sclerosis: The Exploration of a Mediation Model
|
Daba, Muhannad H.
|
|
|
80 |
C |
p.
|
artikel
|
| 89 |
Fatigue and Brain Atrophy in Egyptian Patients with Relapsing Remitting Multiple Sclerosis
|
Khedr, Eman M
|
|
|
80 |
C |
p.
|
artikel
|
| 90 |
Fingolimod: Assay analysis of US generic capsule products reveals variation in fingolimod content beyond the recommended acceptance criteria
|
Wainwright, Catherine
|
|
|
80 |
C |
p.
|
artikel
|
| 91 |
First Three NMOSD Case Series Started on IV Ravulizumab in UAE
|
Salih, Nihal Mohamedelmustafa Abdelrahman
|
|
|
80 |
C |
p.
|
artikel
|
| 92 |
Immune Reconstitution Inflammatory Syndrome After Fingolimod Cessation
|
Mhiri, Mariem
|
|
|
80 |
C |
p.
|
artikel
|
| 93 |
Impact of adherence to disease-modifying drugs in multiple sclerosis: A study on Italian real-world data
|
Belotti, Laura Maria Beatrice
|
|
|
80 |
C |
p.
|
artikel
|
| 94 |
Impact of automatic tools for detecting new lesions on therapeutic strategies offered to patients with MS by neurologists
|
Merkler, Blandine
|
|
|
80 |
C |
p.
|
artikel
|
| 95 |
Implementing Shared Decision-Making for Multiple Sclerosis: The MS-SUPPORT Tool
|
Col, Nananda F
|
|
|
80 |
C |
p.
|
artikel
|
| 96 |
Incidence and Severity of COVID-19 Infection After Pulse Methylprednisolone in Patients with Multiple Sclerosis
|
Poursadeghfard, Maryam
|
|
|
80 |
C |
p.
|
artikel
|
| 97 |
Increased Odds of Alcohol Consumption, Cannabis, and Illicit Substances Use in Cigarette Smoking Multiple Sclerosis Patients
|
Hamidi, Majid
|
|
|
80 |
C |
p.
|
artikel
|
| 98 |
Indirect impact of the COVID-19 pandemic on the care and outcomes of people with MS: A combined survey and insurance claims study
|
Meltzer, Ethan
|
|
|
80 |
C |
p.
|
artikel
|
| 99 |
Influence of Cigarette, and Waterpipe Smoking, Alcohol, and Drug Consumption on the Occurrence of Late-Onset Multiple Sclerosis
|
Kasbi, Naghmeh Abbasi
|
|
|
80 |
C |
p.
|
artikel
|
| 100 |
Infratentorial Lesions as a Radiological Biomarker for Progression Independent of Relapse Activity (PIRA) in Patients with Multiple Sclerosis in Saudi Population
|
Assiri, Faisal
|
|
|
80 |
C |
p.
|
artikel
|
| 101 |
Intrathecal Synthesis of Immunoglobulins G (IgG): A Prognostic Biomarker in Patients with Multiple Sclerosis
|
Moh, Youssouf Ben
|
|
|
80 |
C |
p.
|
artikel
|
| 102 |
Investigating the link between regional oxygen metabolism and cognitive speed in multiple sclerosis: Implications for fatigue
|
Zuppichini, Mark D.
|
|
|
80 |
C |
p.
|
artikel
|
| 103 |
Investigating the Relationship Between Place of Residence and the Prevalence of Tobacco Smoking, Alcohol Consumption, and Drug Abuse in Iranian Multiple Sclerosis Patients
|
Rezaei, Ali
|
|
|
80 |
C |
p.
|
artikel
|
| 104 |
Investigation of Changes in Lymphocyte Subset Counts and their Relationship with MRI Outcomes in the Magnify-MS Study
|
Hodgkinson, Suzanne
|
|
|
80 |
C |
p.
|
artikel
|
| 105 |
Is Hepatitis C Virus Incriminated in Pathogenesis of Multiple Sclerosis?
|
Khater, Shaimaa Sayed
|
|
|
80 |
C |
p.
|
artikel
|
| 106 |
Is multiple sclerosis a glymphaticopathy?
|
Alghanimy, Alaa A
|
|
|
80 |
C |
p.
|
artikel
|
| 107 |
Is There Any Benefit in Extended-Interval Dosing Regimen of Natalizumab for Patients with Relapsing-Remitting Multiple Sclerosis? Results from a Systematic Review and Meta-Analysis
|
Mousavi, Taraneh
|
|
|
80 |
C |
p.
|
artikel
|
| 108 |
Is Weight Loss a Presenting Symptom of Multiple Sclerosis
|
Abuotorabi-Zarchi, Marzie
|
|
|
80 |
C |
p.
|
artikel
|
| 109 |
Late Onset MS and Challenging in Diagnosis and Treatment
|
Abuotorabi-Zarchi, Marzie
|
|
|
80 |
C |
p.
|
artikel
|
| 110 |
Leishmaniasis in a Multiple Sclerosis Patient Under Treatment with Natalizumab
|
Nahayati, Mohammadali
|
|
|
80 |
C |
p.
|
artikel
|
| 111 |
Lesion Location in Patients with Multiple Sclerosis and Restless Leg Syndrome: A Retrospective Study
|
Almarshed, Ahmad
|
|
|
80 |
C |
p.
|
artikel
|
| 112 |
Lessons learned after 20 years of real-world experience with natalizumab
|
Khatri, Bhupendra O.
|
|
|
80 |
C |
p.
|
artikel
|
| 113 |
Long-Term, Comparative Safety Study of People with Multiple Sclerosis Newly Started on Cladribine Tablets (CLARION): Study Status Update and Representativeness
|
Ziemssen, Tjalf
|
|
|
80 |
C |
p.
|
artikel
|
| 114 |
Medical Histories and Comorbidities Among Patients with Neuromyelitis Optica Spectrum Disorder, a Comprehensive Study from Iran
|
Mehdipour, Roshanak
|
|
|
80 |
C |
p.
|
artikel
|
| 115 |
Mediterranean- Style Diets for Fatigue in Multiple Sclerosis: A Systematic Review
|
Abbasi, Hamid
|
|
|
80 |
C |
p.
|
artikel
|
| 116 |
Mitochondrial DNA Copy Number as a Biomarker of Multiple Sclerosis
|
Khater, Shaimaa Sayed
|
|
|
80 |
C |
p.
|
artikel
|
| 117 |
Monocyte Subsets in Relapsing Remitting Multiple Sclerosis Egyptian Patients
|
Khater, Shaimaa Sayed
|
|
|
80 |
C |
p.
|
artikel
|
| 118 |
MRI Assessment of Cervical Spinal Cord Cross Sectional Area in Patients with Multiple Sclerosis in Iraq
|
Hassoun, Hayder K.
|
|
|
80 |
C |
p.
|
artikel
|
| 119 |
MRI graph parameters are longitudinal markers of neuronal integrity in multiple sclerosis
|
Hamwi, Milad
|
|
|
80 |
C |
p.
|
artikel
|
| 120 |
MS in the UAE: Population Estimates of Anxiety, Depression and Health-Related Quality of Life
|
Krishnan, Omeesha Sanjay
|
|
|
80 |
C |
p.
|
artikel
|
| 121 |
Multiple Sclerosis in Elderly Patients: When We Can Stopped Treatment?
|
Oudrer, Naima
|
|
|
80 |
C |
p.
|
artikel
|
| 122 |
Multiple Sclerosis Patients Characteristics in Egypt
|
Hammad, Mohamed Ahmed
|
|
|
80 |
C |
p.
|
artikel
|
| 123 |
Multiple Sclerosis vision questionnaire (MSVQ-7): Reliability, validity, precision and discrimination
|
Young, Carolyn A.
|
|
|
80 |
C |
p.
|
artikel
|
| 124 |
Myelin-Oligodendrocyte Glycoprotein Antibody-Associated Disease and Intracranial Hypertension: A Case Report
|
Mahdaoui, Mohamed
|
|
|
80 |
C |
p.
|
artikel
|
| 125 |
Natalizumab for Moroccan Patients with Highly Active Multiple Sclerosis
|
Moh, Youssouf Ben
|
|
|
80 |
C |
p.
|
artikel
|
| 126 |
Neurological syndromes and potential triggers associated with antibodies to neuronal surface antigens
|
Klein da Costa, Bruna
|
|
|
80 |
C |
p.
|
artikel
|
| 127 |
Neuromyelitis Optica Spectrum Disorder: Clinical, Radiological Features of Seropositive Patients
|
Othman, Oumayma Ben
|
|
|
80 |
C |
p.
|
artikel
|
| 128 |
Neuromyelitis Optica Spectrum Disorders Associated to Posterior Reversible Encephalopathy Syndrome: Pathogenesis, Diagnosis, Treatment and Evolution: A Case Report and Literature Review
|
Moh, Youssouf Ben
|
|
|
80 |
C |
p.
|
artikel
|
| 129 |
New Anti-Cd20 Divozilimab in Relapsing Multiple Sclerosis: Phase III MIRANTIBUS Trial Results
|
Boyko, Alexey
|
|
|
80 |
C |
p.
|
artikel
|
| 130 |
NMO Complicated by a PRES Syndrome as an Initial Manifestation
|
Lhassani, Sara
|
|
|
80 |
C |
p.
|
artikel
|
| 131 |
NMO Impact of Proprioception Impairments in Multiple Sclerosis
|
Etoom, Mohammad
|
|
|
80 |
C |
p.
|
artikel
|
| 132 |
NMO Intelligence Level Among Neuromyelitis Optica Spectrum Disorder Patients from Iranian Society
|
Mehdipour, Roshanak
|
|
|
80 |
C |
p.
|
artikel
|
| 133 |
NMOSD Like Presentation Following Anti-TNFa in Patient with Psoriasis: A Case Report and Review Articles
|
Nahayati, Mohammadali
|
|
|
80 |
C |
p.
|
artikel
|
| 134 |
Non-Compressive Acute Myelitis: Epidemiologic, Clinical, Paraclinical and Evolution Aspects: Study of 48 Cases
|
Moh, Youssouf Ben
|
|
|
80 |
C |
p.
|
artikel
|
| 135 |
Ocrelizumab and Cladribine Had Similar EDSS Stability in Patients with Highly Active Multiple Sclerosis
|
Alroughani, Raed
|
|
|
80 |
C |
p.
|
artikel
|
| 136 |
Ocrelizumab for Pediatric Relapsing Multiple Sclerosis
|
Alroughani, Raed
|
|
|
80 |
C |
p.
|
artikel
|
| 137 |
Ofatumumab in Breast Milk of Multiple Sclerosis Patients
|
Witt, Laura
|
|
|
80 |
C |
p.
|
artikel
|
| 138 |
Ophthalmological Manifestations of Multiple Sclerosis
|
Mhiri, Mariem
|
|
|
80 |
C |
p.
|
artikel
|
| 139 |
Optic Nerve Imaging Solving Demyelination Mystery
|
Galeel, Aya Abdel
|
|
|
80 |
C |
p.
|
artikel
|
| 140 |
Optic Neuritis Epidemiology and Clinical Characteristics in United Arab Emirates
|
Eldweik, Luai
|
|
|
80 |
C |
p.
|
artikel
|
| 141 |
Oral Status of Patients with MS in a Population of Western and Southwestern Algeria
|
Amina, Chentouf
|
|
|
80 |
C |
p.
|
artikel
|
| 142 |
Parental Consanguinity and the Age at Onset in Multiple Sclerosis: A National Registry-Based Analysis of Familial Cases of Iran
|
Eskandarieh, Sharareh
|
|
|
80 |
C |
p.
|
artikel
|
| 143 |
Parental Smoking, Water Pipe and Alcohol Use Before Childbirth and Multiple Sclerosis Onset: A Case-Control Study
|
Bahrami, Sahar Nikkhah
|
|
|
80 |
C |
p.
|
artikel
|
| 144 |
Pediatric anti-NMDAR encephalitis with demyelination on brain MRI: A single center study
|
Li, Yuhang
|
|
|
80 |
C |
p.
|
artikel
|
| 145 |
Pediatric Multiple Sclerosis: to Explain is to Gain
|
Gharsallah, Farah
|
|
|
80 |
C |
p.
|
artikel
|
| 146 |
Pediatric Onset Multiple Sclerosis: Evaluation of Disease Activity in a Tunisian Cohort
|
Gharsallah, Farah
|
|
|
80 |
C |
p.
|
artikel
|
| 147 |
Pediatric Onset Multiple Sclerosis in Kuwait
|
Alroughani, Raed
|
|
|
80 |
C |
p.
|
artikel
|
| 148 |
Perceptions of people with multiple sclerosis on social determinants of health: Mixed methods
|
Mateen, Farrah J.
|
|
|
80 |
C |
p.
|
artikel
|
| 149 |
Persistence to the Oral Disease-Modifying Therapies for Multiple Sclerosis: A Population-Based Study in Iranian Patients
|
Paybast, Sepideh
|
|
|
80 |
C |
p.
|
artikel
|
| 150 |
Personality Traits of Patients with Multiple Sclerosis and their Correlation with Anxiety and Depression Levels
|
Ali, Amal Hadj
|
|
|
80 |
C |
p.
|
artikel
|
| 151 |
Phase 3 REMODEL I/II Trials: Efficacy, Safety, and Tolerability of Remibrutinib in Patients with Relapsing Multiple Sclerosis
|
Wiendl, Heinz
|
|
|
80 |
C |
p.
|
artikel
|
| 152 |
Phenotypes Differences in Patients with Neuromyelitis Optica Spectrum Disorders
|
Irene, Gómez Estevez
|
|
|
80 |
C |
p.
|
artikel
|
| 153 |
Physical Activity in People with Multiple Sclerosis: Which Clinical Characteristics are Important?
|
Almusallam, Mozza
|
|
|
80 |
C |
p.
|
artikel
|
| 154 |
Post-Approval Safety of Cladribine Tablets in the Treatment of Patients with Multiple Sclerosis: 2023 Update
|
Giovannoni, Gavin
|
|
|
80 |
C |
p.
|
artikel
|
| 155 |
Postpartum Management in Multiple Sclerosis: Reducing Relapses and Radiological Activity
|
Oreja-Guevara, Celia
|
|
|
80 |
C |
p.
|
artikel
|
| 156 |
Predictive Factors for the Development of Highly Active Multiple Sclerosis
|
Saoussen, Zmantar
|
|
|
80 |
C |
p.
|
artikel
|
| 157 |
Predictors of Disability and Disease Progression Among a Sample of Multiple Sclerosis Patients: an Egyptian Study
|
Ali, Hagar Saad
|
|
|
80 |
C |
p.
|
artikel
|
| 158 |
Predictors of Progression of Multiple Sclerosis in a Sample of Egyptian Patients
|
Shawky, Manar Ahmed
|
|
|
80 |
C |
p.
|
artikel
|
| 159 |
Predisposed Hla-Drb1 Alleles and EBV Infection Increases MS Susceptibility
|
Kaur, Gurkeerat
|
|
|
80 |
C |
p.
|
artikel
|
| 160 |
Pregnancy and Infant Outcomes in Women Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of the Largest Available Outcomes Database
|
Hellwig, Kerstin
|
|
|
80 |
C |
p.
|
artikel
|
| 161 |
Prevalence and Clinical Characteristics of Urological Symptoms in Iranian Multiple Sclerosis Patients: Implications for Quality of Life and Management
|
Eskandarieh, Sharareh
|
|
|
80 |
C |
p.
|
artikel
|
| 162 |
Prevalence of Neuromyelitis Optica Spectrum Disorder Among Afghan Immigrants and Refugees in Tehran, Iran
|
Jahani, Shima
|
|
|
80 |
C |
p.
|
artikel
|
| 163 |
Primary Biliary Cirrhosis-Autoimmune Hepatitis Overlap in Patient with Multiple Sclerosis Treated with Ocrelizumab: A Case Study and Literature Review
|
Nahayati, Mohammadali
|
|
|
80 |
C |
p.
|
artikel
|
| 164 |
Prognosis of patients with multiple sclerosis associated with uveitis
|
Martin, Marine
|
|
|
80 |
C |
p.
|
artikel
|
| 165 |
Prognostic Factors in Patients with Multiple Sclerosis in Bejaia, Algeria
|
Khellaf, Saddek
|
|
|
80 |
C |
p.
|
artikel
|
| 166 |
Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis
|
Molazadeh, Negar
|
|
|
80 |
C |
p.
|
artikel
|
| 167 |
Quality of Life in Multiple Sclerosis Patients: Yemeni Patients' Experience Using (MSQOL-54) Questionnaire
|
Elawfi, Bashaer
|
|
|
80 |
C |
p.
|
artikel
|
| 168 |
Real-Saudi Experience with Ocrelizumab in Relapsing Multiple Sclerosis
|
Ammari, Maha Al
|
|
|
80 |
C |
p.
|
artikel
|
| 169 |
Real-World Effectiveness of Ocrelizumab in a UK Multi-Centre Paediatric-Onset Multiple Sclerosis Cohort
|
Abdel-Mannan, Omar
|
|
|
80 |
C |
p.
|
artikel
|
| 170 |
Real World Effectiveness of Oral Cladribine in Multiple Sclerosis Treatment, Report from a Single Saudi Center
|
Bohlega, Saeed
|
|
|
80 |
C |
p.
|
artikel
|
| 171 |
Real-World Efficacy and Safety Profile of Ocrelizumab in Adult Emirati Multiple Sclerosis Patients: A Retrospective Study from Cleaveland Clinic Abu Dhabi
|
Altelly, Ahmad
|
|
|
80 |
C |
p.
|
artikel
|
| 172 |
Real-World Evidence with Five-Year Data (2017-2022) on the Use of Cladribine Tablets in Patients with Multiple Sclerosis in England: an Updated Analysis from the CLARENCE Study
|
Brownlee, Wallace
|
|
|
80 |
C |
p.
|
artikel
|
| 173 |
Real World Experience for Cladribine Tablets in Management of Relapsing Multiple Sclerosis in UAE: Cohort Study from Rashid Hospital -Dubai
|
Inshasi, Jihad
|
|
|
80 |
C |
p.
|
artikel
|
| 174 |
Real World Study of Ocrelizumab in Multiple Sclerosis: Kuwait Experience
|
Alroughani, Raed
|
|
|
80 |
C |
p.
|
artikel
|
| 175 |
Rebound of Multiple Sclerosis Disease Activity After Switching from Fingolimod or Natalizumab to Cladribine Tablets: Real World Experience from the Arabian Gulf
|
Inshasi, Jihad
|
|
|
80 |
C |
p.
|
artikel
|
| 176 |
Relation of Lung Microbiome and Multiple Sclerosis
|
Alskaf, Asma Samir
|
|
|
80 |
C |
p.
|
artikel
|
| 177 |
Remibrutinib, a Novel Bruton Tyrosine Kinase Inhibitor, Exhibits Improved Target Selectivity and Potency in Vitro
|
Pulz, Robert
|
|
|
80 |
C |
p.
|
artikel
|
| 178 |
Retinal Nerve Fiber Layer Thickness and Disability in Multiple Sclerosis Patients Among a Tunisian Cohort
|
Rim, Smaoui
|
|
|
80 |
C |
p.
|
artikel
|
| 179 |
Revolutionizing MS Care and Research: Inside Iran's Nationwide Multiple Sclerosis Registry
|
Eskandarieh, Sharareh
|
|
|
80 |
C |
p.
|
artikel
|
| 180 |
Risk Factors Associated with Multiple Sclerosis in Beni Mellal-Khenifra Region, Morocco
|
Lotfi, Rachid
|
|
|
80 |
C |
p.
|
artikel
|
| 181 |
Safety and effectiveness of ofatumumab, a chart review analysis from Sheikh Shakhbout Medical City, Abu Dhabi
|
Samad, Hanin Abdel
|
|
|
80 |
C |
p.
|
artikel
|
| 182 |
Safety and Efficacy of Disease Modifying Therapies After Switching from Natalizumab: A MENACTRIMS Observational Study
|
Zeineddine, Maya
|
|
|
80 |
C |
p.
|
artikel
|
| 183 |
Safety and Efficacy of Evobrutinib and Tolebrutinib in Relapsing Multiple Sclerosis: A Meta-Analysis of Recent Randomized Control Trials
|
Abbas, Abdallah
|
|
|
80 |
C |
p.
|
artikel
|
| 184 |
Safety Evaluation of Fampiridine in Patients with Multiple Sclerosis as a Prospective Cohort Study
|
Vaheb, Saeed
|
|
|
80 |
C |
p.
|
artikel
|
| 185 |
Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis
|
Hauser, Steve L
|
|
|
80 |
C |
p.
|
artikel
|
| 186 |
Salivary Cortisol Levels and Its Associations with Depression, Anxiety, and Quality of Life Among Multiple Sclerosis Patients: A Case-Control Study
|
Mokary, Yousef
|
|
|
80 |
C |
p.
|
artikel
|
| 187 |
Seasonal Variation of Multiple Sclerosis Relapses in Oman
|
Al-Asmi, Abdullah
|
|
|
80 |
C |
p.
|
artikel
|
| 188 |
Self-assessed Dynamic Gait Index correlates with physical therapist assessed Dynamic Gait Index in people with multiple sclerosis
|
Chen, Vicky L.
|
|
|
80 |
C |
p.
|
artikel
|
| 189 |
Self-reports by persons with multiple sclerosis are an adequate surrogate for healthcare provider data on disease-modifying therapy and multiple sclerosis type
|
Stanikić, Mina
|
|
|
80 |
C |
p.
|
artikel
|
| 190 |
Serum Neurofilament Light Chain as a Biomarker for Disease Activity in Relapsing Remitting Multiple Sclerosis Patients
|
Elmotayam, Amal Salah Eldeen
|
|
|
80 |
C |
p.
|
artikel
|
| 191 |
Serum Neurofilament Light Chain as a Biomarker of Disease Progression in a Sample of Egyptian Multiple Sclerosis Patients
|
Ali, Hagar Saad
|
|
|
80 |
C |
p.
|
artikel
|
| 192 |
Serum Oxidative Stress Biomarkers in Relapsing Remitting Multiple Sclerosis Patients with No Evidence of Disease Activity
|
Elmazny, Alaa
|
|
|
80 |
C |
p.
|
artikel
|
| 193 |
Smartwatch-derived sleep and heart rate measures complement step counts in explaining established metrics of MS severity
|
Woelfle, Tim
|
|
|
80 |
C |
p.
|
artikel
|
| 194 |
Subcutaneous Ocrelizumab in Patients with Multiple Sclerosis: Results of the Phase III OCARINA II Study Authors
|
Newsome, SD
|
|
|
80 |
C |
p.
|
artikel
|
| 195 |
Sustained No Evidence of Disease Activity Over 4 Years for Patients Treated with Cladribine Tablets: Cohort Study from Sheikh Shakbout Medical Center, Abu Dhabi
|
Samad, Hanin Abdel
|
|
|
80 |
C |
p.
|
artikel
|
| 196 |
Systematic review and meta-analysis of sedentary behavior in persons with multiple sclerosis
|
Zheng, Peixuan
|
|
|
80 |
C |
p.
|
artikel
|
| 197 |
Telehealth in Multiple Sclerosis: Fostering Quality of Life
|
Jafri, Raabeah Fatma
|
|
|
80 |
C |
p.
|
artikel
|
| 198 |
Thalamic Atrophy, Duration of Illness, and Years of Education are the Best Predictors of Cognitive Impairment in Multiple Sclerosis
|
Khedr, Eman Mohamed
|
|
|
80 |
C |
p.
|
artikel
|
| 199 |
The Adherence and Clinical Outcomes in Patients with Relapsing Multiple Sclerosis Treated with Subcutaneous Interferon Beta-1A: Results from the Main-MS Study
|
Al-Roughani, Raed
|
|
|
80 |
C |
p.
|
artikel
|
| 200 |
The Association Between Anxiety and Dyslipidemia in Patients with Multiple Sclerosis
|
Rezaeimanesh, Nasim
|
|
|
80 |
C |
p.
|
artikel
|
| 201 |
The Association Between Bladder Symptoms and Cognition, Depression, Fatigue, and Anxiety Among Patients with Multiple Sclerosis
|
Rezaeimanesh, Nasim
|
|
|
80 |
C |
p.
|
artikel
|
| 202 |
The Association Between Demographic and Clinical Characteristics with Tobacco Smoking, Alcohol Consumption, and Drug Abuse in Iranian Patients with Multiple Sclerosis (MS)
|
Kohandel, Kosar
|
|
|
80 |
C |
p.
|
artikel
|
| 203 |
The Association Between Duration of Multiple Sclerosis and Risk of Helicobacter Pylori Infection
|
Bayat, Mahnaz
|
|
|
80 |
C |
p.
|
artikel
|
| 204 |
The Association of ApoE Genotype and Cognitive Impairment in Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
|
Sahebari, Sepideh Seyedi
|
|
|
80 |
C |
p.
|
artikel
|
| 205 |
The association of multiple sclerosis with thyroid disease: A meta-analysis
|
Gautam, Sushan
|
|
|
80 |
C |
p.
|
artikel
|
| 206 |
The Correlation Between Serum Level of Interleukin-17A with Cognitive Impairment and Disability in Multiple Sclerosis Patients
|
Rezaeimanesh, Nasim
|
|
|
80 |
C |
p.
|
artikel
|
| 207 |
The Effect of Excessive Use of Smart Phones on Quality of Sleep in Multiple Sclerosis Patients
|
Elmotayam, Amal
|
|
|
80 |
C |
p.
|
artikel
|
| 208 |
The effect of multi-function swing suspension training on upper and lower extremities function and quality of life in multiple sclerosis women with different disability status
|
Far, Sara Sepehri
|
|
|
80 |
C |
p.
|
artikel
|
| 209 |
The Effects of Aerobic Exercise on Urinary Incontinence and Related Biomarkers in Individuals with Multiple Sclerosis: A Pilot Randomized Controlled Trial
|
Al-Sharman, Alham
|
|
|
80 |
C |
p.
|
artikel
|
| 210 |
The Effects of Melatonin Supplementation on Clinical Severity in Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis: A Systematic Review and Meta-Analysis
|
Mosaddeghi-Heris, Reza
|
|
|
80 |
C |
p.
|
artikel
|
| 211 |
The Effects of Melatonin Supplementation on Cognitive Outcomes in Multiple Sclerosis: A Systematic Review
|
Naseri, Amirreza
|
|
|
80 |
C |
p.
|
artikel
|
| 212 |
The Importance of Peripheral Vestibular Assessment in Diagnosing Imbalance in People with Multiple Sclerosis
|
Ravindran, Vinodh
|
|
|
80 |
C |
p.
|
artikel
|
| 213 |
The Management of Lower Urinary Tract Symptoms in Multiple Sclerosis: an Umbrella Review
|
Naseri, Amirreza
|
|
|
80 |
C |
p.
|
artikel
|
| 214 |
The Prevalence of Epstein-Barr Virus and Multiple Sclerosis in Mena Region: A Systematic Review
|
Kasbi, Naghmeh Abbasi
|
|
|
80 |
C |
p.
|
artikel
|
| 215 |
The Role of Chemokines (CCL2, CCL5 and CXCL10) in the Neuroinflammation Among Patients with Multiple Sclerosis
|
Salim, Ahmed Abduljawad
|
|
|
80 |
C |
p.
|
artikel
|
| 216 |
The Role of Gaming Technology in Rehabilitation in Improving Motor and Cognitive Function as Well as Psychological Function in People with Multiple Sclerosis: A Systematic Review
|
Jaradat, Bayan
|
|
|
80 |
C |
p.
|
artikel
|
| 217 |
The Use of Artificial Intelligence in Multiple Sclerosis: A Literature Review
|
Mahdaoui, Mohamed
|
|
|
80 |
C |
p.
|
artikel
|
| 218 |
Time Requirements of Healthcare Professionals for Managing Disease-Modifying Therapies for Multiple Sclerosis in Qatar, Kuwait and Bahrain
|
Abdelmoneim, Mohamed Sayed
|
|
|
80 |
C |
p.
|
artikel
|
| 219 |
Time to Qualifying Relapse by Previous Disease-Modifying Therapy Status in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets Over 2 Years in the CLARIFY-MS Study
|
Patti, Francesco
|
|
|
80 |
C |
p.
|
artikel
|
| 220 |
Tocilizumab treatment in neuromyelitis optica spectrum disorders: Updated meta-analysis of efficacy and safety
|
Wang, Yupeng
|
|
|
80 |
C |
p.
|
artikel
|
| 221 |
Treatment and Outcome in Patients with Progressive Solitary Sclerosis: A Systematic Review
|
Alsaber, Naif
|
|
|
80 |
C |
p.
|
artikel
|
| 222 |
Understanding the Place of Environmental Factors in Familial Aggregation of Multiple Sclerosis
|
Maghbooli, Zhila
|
|
|
80 |
C |
p.
|
artikel
|
| 223 |
Unlocking the Secrets of Multiple Sclerosis Progression: How Machine Learning is Changing the Game
|
Dahshan, Ahmed
|
|
|
80 |
C |
p.
|
artikel
|
| 224 |
Upbeat Nystagmus and Ataxia in a Case of Myelin Oligodendrocyte Glycoprotein (MOG)-IgG-Associated Disease
|
Singh, Amit Shankar
|
|
|
80 |
C |
p.
|
artikel
|
| 225 |
Update on Long-Term Efficacy and Safety of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, Over 5 Years from an Ongoing Phase 2 Open-Label Extension
|
Montalban, Xavier
|
|
|
80 |
C |
p.
|
artikel
|
| 226 |
Utilization of FDA approved treatments for neuromyelitis optica spectrum disorder in clinical practice: A survey study of academic neuroimmunologists
|
Thon, Jesse M.
|
|
|
80 |
C |
p.
|
artikel
|
| 227 |
Work Difficulties Evaluation in People with Multiple Sclerosis: A Tunisian Study
|
Boussaid, Haifa
|
|
|
80 |
C |
p.
|
artikel
|
Tijdschrift beschrijving